Main Competitors

UnitedHealth Group operates in a competitive, complex, and multifaceted landscape, facing diverse participants in each of its business segments.

In Health Insurance (UnitedHealthcare):

UnitedHealth Group's main competitors in the health insurance sector include:

• Cigna Group (CI)

• Centene (CNC)

• CVS Health (CVS)

• Elevance Health (ELV)

• Humana (HUM)

• Johnson & Johnson (JNJ)

• Molina Healthcare (MOH)

In terms of revenue, UnitedHealth Group is the largest health insurance company in the United States, with a market share of 15.7%, followed by Elevance Health (formerly Anthem) with 9.7%, Kaiser Permanente with 9.2%, Centene (formerly Ambetter) with 8.6%, and Humana with 7.3%.

However, by number of members, Kaiser Permanente leads with 8.8 million, followed by Elevance Health with 5.3 million, Centene with 5.2 million, and UnitedHealth Group with 4.8 million. This disparity suggests that, although UnitedHealth Group is a leader in revenue, its focus might be on higher-value plans or specific market segments.

In Pharmacy Benefit Management (Optum Rx):

The PBM market is highly concentrated, with only three companies controlling 80% of the prescription drug market in the United States:

• Optum Rx

• CVS Caremark

• Express Scripts

In 2023, Optum Rx was the largest PBM in rebate negotiation, with a market share of 22.2%, followed by Caremark with 18.9% and Express Scripts with 15.5%.

In Care Delivery and Health Technology Services (OptumHealth and OptumInsight):

OptumHealth: As a direct care organization, it competes with large integrated delivery networks (IDNs) and physician groups. The leading IDNs by net patient revenue include HCA Healthcare, CommonSpirit Health, and Kaiser Permanente.

UnitedHealth Group is positioned as the third-largest "medical group parent" by number of unique affiliated physicians and the first by number of medical group sites.

OptumInsight: Its competitors in health IT solutions, data analytics, and revenue cycle management include Availity, Cerner (now Oracle Health), and Epic.

A Target for Regulatory Scrutiny

UnitedHealth Group has achieved a dominant position in multiple segments of the healthcare sector, being the largest insurer by revenue and a leading PBM. Its expansion into care delivery through OptumHealth reinforces this comprehensive position.

However, this very market concentration, especially in the PBM segment, generates significant regulatory risk. The antitrust lawsuits by the Federal Trade Commission (FTC) against the "Big Three" PBMs demonstrate how UnitedHealth Group's scale, while a strength, also makes it a target for regulatory scrutiny.

The competition for UnitedHealth Group is not limited to market share in insurance or PBM but also extends to the capability to offer value-based care. Kaiser Permanente's leadership in insurance enrollment and its status as a major IDN highlight the importance of integrated care models.

OptumHealth's strategy of partnering with physicians and focusing on value-based care is a direct response to this market trend. UnitedHealth Group's ability to demonstrate that its vertical integration improves health outcomes and reduces overall costs, rather than simply increasing profits, will be critical to its long-term success and to mitigating antitrust concerns.

UnitedHealth Group: What Needs to Happen to Return to New Highs? $UNH